Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2025-12-27 @ 7:29 AM
Study NCT ID:
NCT01485367
Status:
UNKNOWN
Last Update Posted:
2012-04-23
First Post:
2011-11-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Pilot Study to Evaluate The Efficacy of Adapalene 0.3% for Use in the Prevention and Treatment of Senile Purpura
Sponsor:
Multispecialty Aesthetic Clinical Research Organization
Organization:
Study Overview
Official Title:
Phase II Pilot Study to Evaluate The Efficacy of Adapalene 0.3% for Use in The Prevention and Treatment of Senile Purpura
Status:
UNKNOWN
Status Verified Date:
2012-04
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is an open label 6 month pilot study for male and female participants over the age of 52 that desire treatment and prevention of senile purpura of the forearms.
This study will be evaluating the effects of Adapalene 0.3% for the use in the treatment and prevention of senile purpura.
This study will be evaluating the effects of Adapalene 0.3% for the use in the treatment and prevention of senile purpura.
Detailed Description:
This is a new potential use for the product Adapalene 0.3%, which is currently an FDA approved topical treatment used for the treatment of acne.
Senile purpura is a common sign of aging that appears in the form of dark blotches on the skin and is caused by bruising.
Older adults tend to be more prone to bruising, since as people age, their skin becomes thinner and more fragile.
Senile purpura is a common sign of aging that appears in the form of dark blotches on the skin and is caused by bruising.
Older adults tend to be more prone to bruising, since as people age, their skin becomes thinner and more fragile.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: